Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Conditions

Hodgkin Disease 24Lymphoma 21Testicular Neoplasms 6Teratoma 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Non-Hodgkin 5Endodermal Sinus Tumor 5Testicular Germ Cell Tumor 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Follicular 4HIV Infections 4Carcinoma, Embryonal 4Acquired Immunodeficiency Syndrome 4Sarcoma, Kaposi 3Ovarian Neoplasms 3Ovarian Germ Cell Cancer 3Head and Neck Neoplasms 3Teratoma, Testicular 2Seminoma 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Neoplasm Metastasis 2Cardiotoxicity 2Carcinoma, Squamous Cell 2Carcinoma 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Effusion, Malignant 1Mediastinal Neoplasms 1

Interventions

Cisplatin 4Etoposide 3Carboplatin 3etoposide phosphate 2Paclitaxel 2Bleomycin 2pralsetinib 1pembrolizumab 1pegfilgrastim 1Standard of Care 1Specimen Handling 1Respiratory Physiological Phenomena 1Practice Guidelines as Topic 1Platinum 1Pemetrexed 1Magnetic Resonance Spectroscopy 1Injections 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Filgrastim 1Biopsy 1Aprepitant 1130-nm albumin-bound paclitaxel 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms, Germ Cell and Embryonal × Bleomycin × Clear all
NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

NCT02582697 2025-06-15

P3BEP

University of Sydney

Phase 3 Recruiting
500 enrolled

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡